Thyrocare Technologies Limited
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
What Thyrocare files
- Others82
- Investor Meet26
- Important23
- Updates18
- Insider Trade13
- Board Meeting10
API Holdings limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
Thyrocare Technologies Limited has informed the Exchange about Copy of Newspaper Publication pertaining to Notice of transfer of equity shares of the Company to Investor Education and Protection Fund.
The amalgamation of Docon Technologies with API Holdings has been sanctioned. API Holdings will now directly hold the 51.02% (8.12 Cr shares) promoter stake in the Company, simplifying the group structure without changing overall promoter shareholding.
Thyrocare Technologies Limited disclosed some pledging/unpledging activity. Please check pdf for more details.
API Holdings repaid INR 1,700 Cr NCDs, releasing the pledge on 60.92% of Thyrocare's equity shares held by Docon. This frees up the parent's shareholding, with no direct impact on Thyrocare's operations.